Current Challenges and Implications of Proteogenomic Approaches in Prostate Cancer

Ruggles, K.V.; Krug, K.; Wang, X.; Clauser, K.R.; Wang, J.; Payne, S.H.; Fenyö, D.; Zhang, B.; Mani, D.R. Methods, tools and current perspectives in proteogenomics. Mol. Cell. Proteomics, 2017, 16(6), 959-981.
[http://dx.doi.org/10.1074/mcp.MR117.000024] [PMID: 28456751]

Tyers, M.; Mann, M. From genomics to proteomics. Nature, 2003, 422(6928), 193-197.
[http://dx.doi.org/10.1038/nature01510] [PMID: 12634792]

Hernandez-Valladares, M.; Vaudel, M.; Selheim, F.; Berven, F.; Bruserud, Ø. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers. Expert Rev. Proteomics, 2017, 14(8), 649-663.
[http://dx.doi.org/10.1080/14789450.2017.1352474] [PMID: 28693350]

Menschaert, G.; Fenyö, D. Proteogenomics from a bioinformatics angle: A growing field. Mass Spectrom. Rev., 2017, 36(5), 584-599.
[http://dx.doi.org/10.1002/mas.21483] [PMID: 26670565]

Ansong, C.; Purvine, S.O.; Adkins, J.N.; Lipton, M.S.; Smith, R.D. Proteogenomics: needs and roles to be filled by proteomics in genome annotation. Brief. Funct. Genomics Proteomics, 2008, 7(1), 50-62.

Sheynkman, G.M.; Shortreed, M.R.; Cesnik, A.J.; Smith, L.M. Proteogenomics: integrating next-generation sequencing and mass spectrometry to characterize human proteomic variation. Annu. Rev. Anal. Chem. (Palo Alto, Calif.), 2016, 9(1), 521-545.
[http://dx.doi.org/10.1146/annurev-anchem-071015-041722] [PMID: 27049631]

Barbieri, R.; Guryev, V.; Brandsma, C.A.; Suits, F.; Bischoff, R.; Horvatovich, P. Proteogenomics: key driver for clinical discovery and personalized medicine. Adv. Exp. Med. Biol., 2016, 926, 21-47.

Kim, M.S.; Pinto, S.M.; Getnet, D.; Nirujogi, R.S.; Manda, S.S.; Chaerkady, R.; Madugundu, A.K.; Kelkar, D.S.; Isserlin, R.; Jain, S.; Thomas, J.K.; Muthusamy, B.; Leal-Rojas, P.; Kumar, P.; Sahasrabuddhe, N.A.; Balakrishnan, L.; Advani, J.; George, B.; Renuse, S.; Selvan, L.D.N.; Patil, A.H.; Nanjappa, V.; Radhakrishnan, A.; Prasad, S.; Subbannayya, T.; Raju, R.; Kumar, M.; Sreenivasamurthy, S.K.; Marimuthu, A.; Sathe, G.J.; Chavan, S.; Datta, K.K.; Subbannayya, Y.; Sahu, A.; Yelamanchi, S.D.; Jayaram, S.; Rajagopalan, P.; Sharma, J.; Murthy, K.R.; Syed, N.; Goel, R.; Khan, A.A.; Ahmad, S.; Dey, G.; Mudgal, K.; Chatterjee, A.; Huang, T.C.; Zhong, J.; Wu, X.; Shaw, P.G.; Freed, D.; Zahari, M.S.; Mukherjee, K.K.; Shankar, S.; Mahadevan, A.; Lam, H.; Mitchell, C.J.; Shankar, S.K.; Satishchandra, P.; Schroeder, J.T.; Sirdeshmukh, R.; Maitra, A.; Leach, S.D.; Drake, C.G.; Halushka, M.K.; Prasad, T.S.K.; Hruban, R.H.; Kerr, C.L.; Bader, G.D.; Iacobuzio-Donahue, C.A.; Gowda, H.; Pandey, A. A draft map of the human proteome. Nature, 2014, 509(7502), 575-581.
[http://dx.doi.org/10.1038/nature13302] [PMID: 24870542]

Zhang, B.; Whiteaker, J.R.; Hoofnagle, A.N.; Baird, G.S.; Rodland, K.D.; Paulovich, A.G. Clinical potential of mass spectrometry-based proteogenomics. Nat. Rev. Clin. Oncol., 2019, 16(4), 256-268.
[http://dx.doi.org/10.1038/s41571-018-0135-7] [PMID: 30487530]

Boja, E.S.; Rodriguez, H. Proteogenomic convergence for understanding cancer pathways and networks. Clin. Proteomics, 2014, 11(1), 22.
[http://dx.doi.org/10.1186/1559-0275-11-22] [PMID: 24994965]

Safonova, Y.; Pevzner, P.A. De novo inference of diversity genes and analysis of non-canonical v(dd)j recombination in immunoglobulins. Front. Immunol., 2019, 10, 987.
[http://dx.doi.org/10.3389/fimmu.2019.00987] [PMID: 31134072]

Sigdel, T.K.; Sarwal, M.M. The proteogenomic path towards biomarker discovery. Pediatr. Transplant., 2008, 12(7), 737-747.
[http://dx.doi.org/10.1111/j.1399-3046.2008.01018.x] [PMID: 18764911]

Dinger, M.E.; Pang, K.C.; Mercer, T.R.; Mattick, J.S. Differentiating protein-coding and noncoding RNA: challenges and ambiguities. PLOS Comput. Biol., 2008, 4(11), e1000176
[http://dx.doi.org/10.1371/journal.pcbi.1000176] [PMID: 19043537]

Storz, G.; Wolf, Y.I.; Ramamurthi, K.S. Small proteins can no longer be ignored. Annu. Rev. Biochem., 2014, 83, 753-777.
[http://dx.doi.org/10.1146/annurev-biochem-070611-102400] [PMID: 24606146]

Yang, X.; Tschaplinski, T.J.; Hurst, G.B.; Jawdy, S.; Abraham, P.E.; Lankford, P.K.; Adams, R.M.; Shah, M.B.; Hettich, R.L.; Lindquist, E.; Kalluri, U.C.; Gunter, L.E.; Pennacchio, C.; Tuskan, G.A. Discovery and annotation of small proteins using genomics, proteomics, and computational approaches. Genome Res., 2011, 21(4), 634-641.
[http://dx.doi.org/10.1101/gr.109280.110] [PMID: 21367939]

Slavoff, S.A.; Mitchell, A.J.; Schwaid, A.G.; Cabili, M.N.; Ma, J.; Levin, J.Z.; Karger, A.D.; Budnik, B.A.; Rinn, J.L.; Saghatelian, A. Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat. Chem. Biol., 2013, 9(1), 59-64.
[http://dx.doi.org/10.1038/nchembio.1120] [PMID: 23160002]

Li, J.; Su, Z.; Ma, Z.Q.; Slebos, R.J.C.; Halvey, P.; Tabb, D.L.; Liebler, D.C.; Pao, W.; Zhang, B. A bioinformatics workflow for variant peptide detection in shotgun proteomics. Mol. Cell. Proteomics, 2011, 10(5), 006536
[http://dx.doi.org/10.1074/mcp.M110.006536] [PMID: 21389108]

Zhang, B.; Wang, J.; Wang, X.; Zhu, J.; Liu, Q.; Shi, Z.; Chambers, M.C.; Zimmerman, L.J.; Shaddox, K.F.; Kim, S.; Davies, S.R.; Wang, S.; Wang, P.; Kinsinger, C.R.; Rivers, R.C.; Rodriguez, H.; Townsend, R.R.; Ellis, M.J.C.; Carr, S.A.; Tabb, D.L.; Coffey, R.J.; Slebos, R.J.C.; Liebler, D.C.; Gillette, M.A.; Klauser, K.R.; Kuhn, E.; Mani, D.R.; Mertins, P.; Ketchum, K.A.; Paulovich, A.G.; Whiteaker, J.R.; Edwards, N.J.; McGarvey, P.B.; Madhavan, S.; Chan, D.; Pandey, A.; Shih, I.M.; Zhang, H.; Zhang, Z.; Zhu, H.; Whiteley, G.A.; Skates, S.J.; White, F.M.; Levine, D.A.; Boja, E.S.; Hiltke, T.; Mesri, M.; Shaw, K.M.; Stein, S.E.; Fenyo, D.; Liu, T.; McDermott, J.E.; Payne, S.H.; Rodland, K.D.; Smith, R.D.; Rudnick, P.; Snyder, M.; Zhao, Y.; Chen, X.; Ransohoff, D.F.; Hoofnagle, A.N.; Sanders, M.E.; Wang, Y.; Ding, L. NCI CPTAC. Proteogenomic characterization of human colon and rectal cancer. Nature, 2014, 513(7518), 382-387.
[http://dx.doi.org/10.1038/nature13438] [PMID: 25043054]

Edwards, N.J. Novel peptide identification from tandem mass spectra using ESTs and sequence database compression. Mol. Syst. Biol., 2007, 3, 102.
[http://dx.doi.org/10.1038/msb4100142] [PMID: 17437027]

Li, J.; Liu, C. Coding or noncoding, the converging concepts of RNAs. Front. Genet., 2019, 10, 496.
[http://dx.doi.org/10.3389/fgene.2019.00496] [PMID: 31178900]

Kung, J.T.Y.; Colognori, D.; Lee, J.T. Long noncoding RNAs: Past, present, and future. Genetics, 2013, 193(3), 651-669.

Prensner, J.R.; Chinnaiyan, A.M. The emergence of lncRNAs in cancer biology. Cancer Discov., 2011, 1(5), 391-407.
[http://dx.doi.org/10.1158/2159-8290.CD-11-0209] [PMID: 22096659]

Suravajhala, P.; Kogelman, L.J.A.; Mazzoni, G.; Kadarmideen, H.N. Potential role of lncRNA cyp2c91-protein interactions on diseases of the immune system. Front. Genet., 2015, 6, 255.
[http://dx.doi.org/10.3389/fgene.2015.00255] [PMID: 26284111]

Arsène-Ploetze, F.; Bertin, P.N.; Carapito, C. Proteomic tools to decipher microbial community structure and functioning. Environ. Sci. Pollut. Res. Int., 2015, 22(18), 13599-13612.
[http://dx.doi.org/10.1007/s11356-014-3898-0] [PMID: 25475614]

Delmotte, N.; Knief, C.; Chaffron, S.; Innerebner, G.; Roschitzki, B.; Schlapbach, R.; Von Mering, C.; Vorholt, J.A. Community proteogenomics reveals insights into the physiology of phyllosphere bacteria. Proc. Natl. Acad. Sci. USA, 2009, 106(38), 16428-16433.
[http://dx.doi.org/10.1073/pnas.0905240106]

Schiebenhoefer, H.; Van Den Bossche, T.; Fuchs, S.; Renard, B.Y.; Muth, T.; Martens, L. Challenges and promise at the interface of metaproteomics and genomics: an overview of recent progress in metaproteogenomic data analysis. Expert Rev. Proteomics, 2019, 16(5), 375-390.
[http://dx.doi.org/10.1080/14789450.2019.1609944] [PMID: 31002542]

Tang, J.; Wang, Y.; Fu, J.; Zhou, Y.; Luo, Y.; Zhang, Y.; Li, B.; Yang, Q.; Xue, W.; Lou, Y.; Qiu, Y.; Zhu, F. A critical assessment of the feature selection methods used for biomarker discovery in current metaproteomics studies. Brief. Bioinform., 2019.
[http://dx.doi.org/10.1093/bib/bbz061] [PMID: 31197323]

Nishimura, T.; Nakamura, H. Developments for personalized medicine of lung cancer subtypes: mass spectrometry-based clinical proteogenomic analysis of oncogenic mutations. Adv. Exp. Med. Biol., 2016, 926, 115-137.

Staal, J.A.; Pei, Y.; Rood, B.R. A proteogenomic approach to understanding MYC function in metastatic medulloblastoma tumors. Int. J. Mol. Sci., 2016, 17(10), E1744
[http://dx.doi.org/10.3390/ijms17101744] [PMID: 27775567]

Offit, K. Personalized medicine: new genomics, old lessons. Hum. Genet., 2011, 130(1), 3-14.
[http://dx.doi.org/10.1007/s00439-011-1028-3] [PMID: 21706342]

De Angelis, G.; Rittenhouse, H.G.; Mikolajczyk, S.D.; Blair Shamel, L.; Semjonow, A. twenty years of psa: from prostate antigen to tumor marker. Rev. Urol., 2007, 9(3), 113-123.
[PMID: 17934568]

Lin, W.; Cao, D.; Shen, K. Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study. Cancer Manag. Res., 2018, 10, 6913-6920.
[http://dx.doi.org/10.2147/CMAR.S186258] [PMID: 30588097]

Zwakman, N.; van de Laar, R.; Van Gorp, T.; Zusterzeel, P.L.M.; Snijders, M.P.M.L.; Ferreira, I.; Massuger, L.F.A.G.; Kruitwagen, R.F.P.M. Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer. J. Gynecol. Oncol., 2017, 28(1), e7
[http://dx.doi.org/10.3802/jgo.2017.28.e7] [PMID: 27670261]

He, Y.; Mohamedali, A.; Huang, C.; Baker, M.S.; Nice, E.C. Oncoproteomics: Current status and future opportunities. Clin. Chim. Acta, 2019, 495, 611-624.
[http://dx.doi.org/10.1016/j.cca.2019.06.006] [PMID: 31176645]

Tomczak, K.; Czerwińska, P.; Wiznerowicz, M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. (Pozn.), 2015, 19(1A), A68-A77.
[http://dx.doi.org/10.5114/wo.2014.47136] [PMID: 25691825]

Devabhaktuni, A.; Elias, J.E. Application of de novo sequencing to large-scale complex proteomics data sets. J. Proteome Res., 2016, 15(3), 732-742.
[http://dx.doi.org/10.1021/acs.jproteome.5b00861] [PMID: 26743026]

Yadav, M.; Jhunjhunwala, S.; Phung, Q.T.; Lupardus, P.; Tanguay, J.; Bumbaca, S.; Franci, C.; Cheung, T.K.; Fritsche, J.; Weinschenk, T.; Modrusan, Z.; Mellman, I.; Lill, J.R.; Delamarre, L. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature, 2014, 515(7528), 572-576.
[http://dx.doi.org/10.1038/nature14001] [PMID: 25428506]

Wang, X.; Slebos, R.J.C.; Wang, D.; Halvey, P.J.; Tabb, D.L.; Liebler, D.C.; Zhang, B. Protein identification using customized protein sequence databases derived from RNA-Seq data. J. Proteome Res., 2012, 11(2), 1009-1017.
[http://dx.doi.org/10.1021/pr200766z] [PMID: 22103967]

Lee, M.; Lee, K.; Yu, N.; Jang, I.; Choi, I.; Kim, P. EunJang, Y.; Kim, B.; Kim, S.; Lee, B.; Kang, J.; Lee, S. ChimerDB 3.0: An enhanced database for fusion genes from cancer transcriptome and literature data mining. Nucleic Acids Res., 2017, 45(Database issue), D784-D789.

Jagtap, P.D.; Johnson, J.E.; Onsongo, G.; Sadler, F.W.; Murray, K.; Wang, Y.; Shenykman, G.M.; Bandhakavi, S.; Smith, L.M.; Griffin, T.J. Flexible and accessible workflows for improved proteogenomic analysis using the Galaxy framework. J. Proteome Res., 2014, 13(12), 5898-5908.
[http://dx.doi.org/10.1021/pr500812t] [PMID: 25301683]

Kumar, D.; Dash, D. Proteogenomic tools and approaches to explore protein coding landscapes of eukaryotic genomes. Adv. Exp. Med. Biol., 2016, 926, 1-10.
[http://dx.doi.org/10.1007/978-3-319-42316-6_1]

Castellana, N.E.; Shen, Z.; He, Y.; Walley, J.W.; Cassidy, C.J.; Briggs, S.P.; Bafna, V. An automated proteogenomic method uses mass spectrometry to reveal novel genes in Zea mays. Mol. Cell. Proteomics, 2014, 13(1), 157-167.
[http://dx.doi.org/10.1074/mcp.M113.031260] [PMID: 24142994]

Risk, B.A.; Spitzer, W.J.; Giddings, M.C. Peppy: proteogenomic search software. J. Proteome Res., 2013, 12(6), 3019-3025.
[http://dx.doi.org/10.1021/pr400208w] [PMID: 23614390]

Ghali, F.; Krishna, R.; Perkins, S.; Collins, A.; Xia, D.; Wastling, J.; Jones, A.R. ProteoAnnotator--open source proteogenomics annotation software supporting PSI standards. Proteomics, 2014, 14(23-24), 2731-2741.
[http://dx.doi.org/10.1002/pmic.201400265] [PMID: 25297486]

Krasnov, G.S.; Dmitriev, A.A.; Kudryavtseva, A.V.; Shargunov, A.V.; Karpov, D.S.; Uroshlev, L.A.; Melnikova, N.V.; Blinov, V.M.; Poverennaya, E.V.; Archakov, A.I.; Lisitsa, A.V.; Ponomarenko, E.A. PPLine: An automated pipeline for SNP, SAP, and splice variant detection in the context of proteogenomics. J. Proteome Res., 2015, 14(9), 3729-3737.
[http://dx.doi.org/10.1021/acs.jproteome.5b00490] [PMID: 26147802]

Wang, X.; Zhang, B.; Wren, J. customProDB: an R package to generate customized protein databases from RNA-Seq data for proteomics search. Bioinformatics, 2013, 29(24), 3235-3237.
[http://dx.doi.org/10.1093/bioinformatics/btt543] [PMID: 24058055]

Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics, 2009, 25(14), 1754-1760.
[http://dx.doi.org/10.1093/bioinformatics/btp324] [PMID: 19451168]

Langmead, B.; Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods, 2012, 9(4), 357-359.
[http://dx.doi.org/10.1038/nmeth.1923] [PMID: 22388286]

Langmead, B. Aligning short sequencing reads with bowtie. Curr. Protoc. Bioinformatics, 2010, 11(11), 7.
[http://dx.doi.org/10.1002/0471250953.bi1107s32]

Crappé, J.; Ndah, E.; Koch, A.; Steyaert, S.; Gawron, D.; De Keulenaer, S.; De Meester, E.; De Meyer, T.; Van Criekinge, W.; Van Damme, P.; Menschaert, G. PROTEOFORMER: deep proteome coverage through ribosome profiling and MS integration. Nucleic Acids Res., 2015, 43(5), e29
[http://dx.doi.org/10.1093/nar/gku1283] [PMID: 25510491]

Zickmann, F.; Renard, B.Y. MSProGene: integrative proteogenomics beyond six-frames and single nucleotide polymorphisms. Bioinformatics, 2015, 31(12), 106-115.
[http://dx.doi.org/10.1093/bioinformatics/btv236]

Shi, Z.; Wang, J.; Zhang, B. NetGestalt: integrating multidimensional omics data over biological networks. Nat. Methods, 2013, 10(7), 597-598.
[http://dx.doi.org/10.1038/nmeth.2517] [PMID: 23807191]

Wang, J.; Duncan, D.; Shi, Z.; Zhang, B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res., , 2013, 41(Web Server issue ), W77 -83.
[http://dx.doi.org/10.1093/nar/gkt439] [PMID: 23703215]

Yang, C.Y.; Chang, C.H.; Yu, Y.L.; Lin, T.C.E.; Lee, S.A.; Yen, C.C.; Yang, J.M.; Lai, J.M.; Hong, Y.R.; Tseng, T.L.; Chao, K.M.; Huang, C.Y.F. PhosphoPOINT: A comprehensive human kinase interactome and phospho-protein database. Bioinformatics, 2008, 24(16), 14-20.
[http://dx.doi.org/10.1093/bioinformatics/btn297]

Tyanova, S.; Temu, T.; Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc., 2016, 11(12), 2301-2319.
[http://dx.doi.org/10.1038/nprot.2016.136] [PMID: 27809316]

Reimand, J.; Bader, G.D. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Mol. Syst. Biol., 2013, 9, 637.
[http://dx.doi.org/10.1038/msb.2012.68] [PMID: 23340843]

Röst, H.L.; Sachsenberg, T.; Aiche, S.; Bielow, C.; Weisser, H.; Aicheler, F.; Andreotti, S.; Ehrlich, H.C.; Gutenbrunner, P.; Kenar, E.; Liang, X.; Nahnsen, S.; Nilse, L.; Pfeuffer, J.; Rosenberger, G.; Rurik, M.; Schmitt, U.; Veit, J.; Walzer, M.; Wojnar, D.; Wolski, W.E.; Schilling, O.; Choudhary, J.S.; Malmström, L.; Aebersold, R.; Reinert, K.; Kohlbacher, O.; Open, M.S. OpenMS: a flexible open-source software platform for mass spectrometry data analysis. Nat. Methods, 2016, 13(9), 741-748.
[http://dx.doi.org/10.1038/nmeth.3959] [PMID: 27575624]

Vaudel, M.; Burkhart, J.M.; Zahedi, R.P.; Oveland, E.; Berven, F.S.; Sickmann, A.; Martens, L.; Barsnes, H. PeptideShaker enables reanalysis of ms-derived proteomics data sets: to the editor. Nat. Biotechnol., 2015, 33, 22-24.
[http://dx.doi.org/10.1038/nbt.3109]

Nagaraj, S.H.; Waddell, N.; Madugundu, A.K.; Wood, S.; Jones, A.; Mandyam, R.A.; Nones, K.; Pearson, J.V.; Grimmond, S.M. PGTools: A software suite for proteogenomic data analysis and visualization. J. Proteome Res., 2015, 14(5), 2255-2266.
[http://dx.doi.org/10.1021/acs.jproteome.5b00029] [PMID: 25760677]

Shukla, H.D. Comprehensive analysis of cancer-proteogenome to identify biomarkers for the early diagnosis and prognosis of cancer. Proteomes, 2017, 5(4), E28
[http://dx.doi.org/10.3390/proteomes5040028] [PMID: 29068423]

Rudnick, P.A.; Markey, S.P.; Roth, J.; Mirokhin, Y.; Yan, X.; Tchekhovskoi, D.V.; Edwards, N.J.; Thangudu, R.R.; Ketchum, K.A.; Kinsinger, C.R.; Mesri, M.; Rodriguez, H.; Stein, S.E. A description of the clinical proteomic tumor analysis consortium (cptac) common data analysis pipeline. J. Proteome Res., 2016, 15(3), 1023-1032.
[http://dx.doi.org/10.1021/acs.jproteome.5b01091] [PMID: 26860878]

Wu, P.; Heins, Z.J.; Muller, J.T.; Katsnelson, L.; de Bruijn, I.; Abeshouse, A.A.; Schultz, N.; Fenyö, D.; Gao, J. Integration and analysis of cptac proteomics data in the context of cancer genomics in the cbioportal. Mol. Cell. Proteomics, 2019, 18(9), 1893-1898.
[http://dx.doi.org/10.1074/mcp.TIR119.001673] [PMID: 31308250]

Vasaikar, S.; Huang, C.; Wang, X.; Petyuk, V.A.; Savage, S.R.; Wen, B.; Dou, Y.; Zhang, Y.; Shi, Z.; Arshad, O.A.; Gritsenko, M.A.; Zimmerman, L.J.; McDermott, J.E.; Clauss, T.R.; Moore, R.J.; Zhao, R.; Monroe, M.E.; Wang, Y.T.; Chambers, M.C.; Slebos, R.J.C.; Lau, K.S.; Mo, Q.; Ding, L.; Ellis, M.; Thiagarajan, M.; Kinsinger, C.R.; Rodriguez, H.; Smith, R.D.; Rodland, K.D.; Liebler, D.C.; Liu, T.; Zhang, B.; Ellis, M.J.C.; Bavarva, J.; Borucki, M.; Elburn, K.; Hannick, L.; Vatanian, N.; Payne, S.H.; Carr, S.A.; Clauser, K.R.; Gillette, M.A.; Kuhn, E.; Mani, D.R.; Cai, S.; Ketchum, K.A.; Thangudu, R.R.; Whiteley, G.A.; Paulovich, A.; Whiteaker, J.; Edward, N.J.; Madhavan, S.; McGarvey, P.B.; Chan, D.W.; Shih, I.M.; Zhang, H.; Zhang, Z.; Zhu, H.; Skates, S.J.; White, F.M.; Mertins, P.; Pandey, A.; Slebos, R.J.C.; Boja, E.; Hiltke, T.; Mesri, M.; Rivers, R.C.; Stein, S.E.; Fenyo, D.; Ruggles, K.; Levine, D.A.; Oberti, M.; Rudnick, P.A.; Snyder, M.; Tabb, D.L.; Zhao, Y.; Chen, X.; Ransohoff, D.F.; Hoofnagle, A.; Sanders, M.E.; Wang, Y.; Davies, S.R.; Townsend, R.R.; Watson, M. Clinical proteomic tumor analysis consortium. proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell, 2019, 177(4), 1035-1049.e19.
[http://dx.doi.org/10.1016/j.cell.2019.03.030] [PMID: 31031003]

Mertins, P.; Mani, D.R.; Ruggles, K.V.; Gillette, M.A.; Clauser, K.R.; Wang, P.; Wang, X.; Qiao, J.W.; Cao, S.; Petralia, F.; Kawaler, E.; Mundt, F.; Krug, K.; Tu, Z.; Lei, J.T.; Gatza, M.L.; Wilkerson, M.; Perou, C.M.; Yellapantula, V.; Huang, K.L.; Lin, C.; McLellan, M.D.; Yan, P.; Davies, S.R.; Townsend, R.R.; Skates, S.J.; Wang, J.; Zhang, B.; Kinsinger, C.R.; Mesri, M.; Rodriguez, H.; Ding, L.; Paulovich, A.G.; Fenyö, D.; Ellis, M.J.; Carr, S.A. NCI CPTAC. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature, 2016, 534(7605), 55-62.
[http://dx.doi.org/10.1038/nature18003] [PMID: 27251275]

Zhang, H.; Liu, T.; Zhang, Z.; Payne, S.H.; Zhang, B.; McDermott, J.E.; Zhou, J.Y.; Petyuk, V.A.; Chen, L.; Ray, D.; Sun, S.; Yang, F.; Chen, L.; Wang, J.; Shah, P.; Cha, S.W.; Aiyetan, P.; Woo, S.; Tian, Y.; Gritsenko, M.A.; Clauss, T.R.; Choi, C.; Monroe, M.E.; Thomas, S.; Nie, S.; Wu, C.; Moore, R.J.; Yu, K.H.; Tabb, D.L.; Fenyö, D.; Bafna, V.; Wang, Y.; Rodriguez, H.; Boja, E.S.; Hiltke, T.; Rivers, R.C.; Sokoll, L.; Zhu, H.; Shih, I.M.; Cope, L.; Pandey, A.; Zhang, B.; Snyder, M.P.; Levine, D.A.; Smith, R.D.; Chan, D.W.; Rodland, K.D.; Carr, S.A.; Gillette, M.A.; Klauser, K.R.; Kuhn, E.; Mani, D.R.; Mertins, P.; Ketchum, K.A.; Thangudu, R.; Cai, S.; Oberti, M.; Paulovich, A.G.; Whiteaker, J.R.; Edwards, N.J.; McGarvey, P.B.; Madhavan, S.; Wang, P.; Whiteley, G.A.; Skates, S.J.; White, F.M.; Kinsinger, C.R.; Mesri, M.; Shaw, K.M.; Stein, S.E.; Fenyo, D.; Rudnick, P.; Snyder, M.; Zhao, Y.; Chen, X.; Ransohoff, D.F.; Hoofnagle, A.N.; Liebler, D.C.; Sanders, M.E.; Shi, Z.; Slebos, R.J.C.; Zimmerman, L.J.; Davies, S.R.; Ding, L.; Ellis, M.J.C.; Townsend, R.R. CPTAC investigators. integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell, 2016, 166(3), 755-765.
[http://dx.doi.org/10.1016/j.cell.2016.05.069] [PMID: 27372738]

Stewart, P.A.; Welsh, E.A.; Slebos, R.J.C.; Fang, B.; Izumi, V.; Chambers, M.; Zhang, G.; Cen, L.; Pettersson, F.; Zhang, Y.; Chen, Z.; Cheng, C.H.; Thapa, R.; Thompson, Z.; Fellows, K.M.; Francis, J.M.; Saller, J.J.; Mesa, T.; Zhang, C.; Yoder, S.; DeNicola, G.M.; Beg, A.A.; Boyle, T.A.; Teer, J.K.; Ann Chen, Y.; Koomen, J.M.; Eschrich, S.A.; Haura, E.B. Proteogenomic landscape of squamous cell lung cancer. Nat. Commun., 2019, 10(1), 3578.
[http://dx.doi.org/10.1038/s41467-019-11452-x] [PMID: 31395880]

Zhao, Q.; Laverdure, J.P.; Lanoix, J.; Durette, C.; Côté, C.; Bonneil, É.; Laumont, C.M.; Gendron, P.; Vincent, K.; Courcelles, M.; Lemieux, S.; Millar, D.G.; Ohashi, P.S.; Thibault, P.; Perreault, C. Proteogenomics uncovers a vast repertoire of shared tumor-specific antigens in ovarian cancer. Cancer Immunol. Res., 2020, 8(4), 544-555.
[http://dx.doi.org/10.1158/2326-6066.CIR-19-0541] [PMID: 32047025]

Ayala, A.G.; Ro, J.Y. Prostatic intraepithelial neoplasia: recent advances. Arch. Pathol. Lab. Med., 2007, 131(8), 1257-1266.
[PMID: 17683188]

Cuzick, J.; Thorat, M.A.; Andriole, G.; Brawley, O.W.; Brown, P.H.; Culig, Z.; Eeles, R.A.; Ford, L.G.; Hamdy, F.C.; Holmberg, L.; Ilic, D.; Key, T.J.; La Vecchia, C.; Lilja, H.; Marberger, M.; Meyskens, F.L.; Minasian, L.M.; Parker, C.; Parnes, H.L.; Perner, S.; Rittenhouse, H.; Schalken, J.; Schmid, H.P.; Schmitz-Dräger, B.J.; Schröder, F.H.; Stenzl, A.; Tombal, B.; Wilt, T.J.; Wolk, A. Prevention and early detection of prostate cancer. Lancet Oncol., 2014, 15(11), e484-e492.
[http://dx.doi.org/10.1016/S1470-2045(14)70211-6] [PMID: 25281467]

Karantanos, T.; Corn, P.G.; Thompson, T.C. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene, 2013, 32(49), 5501-5511.
[http://dx.doi.org/10.1038/onc.2013.206] [PMID: 23752182]

Arora, K.; Barbieri, C.E. Molecular subtypes of prostate cancer. Curr. Oncol. Rep., 2018, 20(8), 58.
[http://dx.doi.org/10.1007/s11912-018-0707-9] [PMID: 29858674]

Hieronymus, H.; Schultz, N.; Gopalan, A.; Carver, B.S.; Chang, M.T.; Xiao, Y.; Heguy, A.; Huberman, K.; Bernstein, M.; Assel, M.; Murali, R.; Vickers, A.; Scardino, P.T.; Sander, C.; Reuter, V.; Taylor, B.S.; Sawyers, C.L. Copy number alteration burden predicts prostate cancer relapse. Proc. Natl. Acad. Sci. USA, 2014, 111(30), 11139-11144.
[http://dx.doi.org/10.1073/pnas.1411446111]

Abeshouse, A.; Ahn, J.; Akbani, R.; Ally, A.; Amin, S.; Andry, C.D.; Annala, M.; Aprikian, A.; Armenia, J.; Arora, A.; Auman, J.T.; Balasundaram, M.; Balu, S.; Barbieri, C.E.; Bauer, T.; Benz, C.C.; Bergeron, A.; Beroukhim, R.; Berrios, M.; Bivol, A.; Bodenheimer, T.; Boice, L.; Bootwalla, M.S.; Borges Dos Reis, R.; Boutros, P.C.; Bowen, J.; Bowlby, R.; Boyd, J.; Bradley, R.K.; Breggia, A.; Brimo, F.; Bristow, C.A.; Brooks, D.; Broom, B.M.; Bryce, A.H.; Bubley, G.; Burks, E.; Butterfield, Y.S.N.; Button, M.; Canes, D.; Carlotti, C.G.; Carlsen, R.; Carmel, M.; Carroll, P.R.; Carter, S.L.; Cartun, R.; Carver, B.S.; Chan, J.M.; Chang, M.T.; Chen, Y.; Cherniack, A.D.; Chevalier, S.; Chin, L.; Cho, J.; Chu, A.; Chuah, E.; Chudamani, S.; Cibulskis, K.; Ciriello, G.; Clarke, A.; Cooperberg, M.R.; Corcoran, N.M.; Costello, A.J.; Cowan, J.; Crain, D.; Curley, E.; David, K.; Demchok, J.A.; Demichelis, F.; Dhalla, N.; Dhir, R.; Doueik, A.; Drake, B.; Dvinge, H.; Dyakova, N.; Felau, I.; Ferguson, M.L.; Frazer, S.; Freedland, S.; Fu, Y.; Gabriel, S.B.; Gao, J.; Gardner, J.; Gastier-Foster, J.M.; Gehlenborg, N.; Gerken, M.; Gerstein, M.B.; Getz, G.; Godwin, A.K.; Gopalan, A.; Graefen, M.; Graim, K.; Gribbin, T.; Guin, R.; Gupta, M.; Hadjipanayis, A.; Haider, S.; Hamel, L.; Hayes, D.N.; Heiman, D.I.; Hess, J.; Hoadley, K.A.; Holbrook, A.H.; Holt, R.A.; Holway, A.; Hovens, C.M.; Hoyle, A.P.; Huang, M.; Hutter, C.M.; Ittmann, M.; Iype, L.; Jefferys, S.R.; Jones, C.D.; Jones, S.J.M.; Juhl, H.; Kahles, A.; Kane, C.J.; Kasaian, K.; Kerger, M.; Khurana, E.; Kim, J.; Klein, R.J.; Kucherlapati, R.; Lacombe, L.; Ladanyi, M.; Lai, P.H.; Laird, P.W.; Lander, E.S.; Latour, M.; Lawrence, M.S.; Lau, K.; Lebien, T.; Lee, D.; Lee, S.; Van Lehmann, K.; Leraas, K.M.; Leshchiner, I.; Leung, R.; Libertino, J.A.; Lichtenberg, T.M.; Lin, P.; Linehan, W.M.; Ling, S.; Lippman, S.M.; Liu, J.; Liu, W.; Lochovsky, L.; Loda, M.; Logothetis, C.; Lolla, L.; Longacre, T.; Lu, Y.; Luo, J.; Ma, Y.; Mahadeshwar, H.S.; Mallery, D.; Mariamidze, A.; Marra, M.A.; Mayo, M.; McCall, S.; McKercher, G.; Meng, S.; Mes-Masson, A.M.; Merino, M.J.; Meyerson, M.; Mieczkowski, P.A.; Mills, G.B.; Shaw, K.R.M.; Minner, S.; Moinzadeh, A.; Moore, R.A.; Morris, S.; Morrison, C.; Mose, L.E.; Mungall, A.J.; Murray, B.A.; Myers, J.B.; Naresh, R.; Nelson, J.; Nelson, M.A.; Nelson, P.S.; Newton, Y.; Noble, M.S.; Noushmehr, H.; Nykter, M.; Pantazi, A.; Parfenov, M.; Park, P.J.; Parker, J.S.; Paulauskis, J.; Penny, R.; Perou, C.M.; Piché, A.; Pihl, T.; Pinto, P.A.; Prandi, D.; Protopopov, A.; Ramirez, N.C.; Rao, A.; Rathmell, W.K.; Rätsch, G.; Ren, X.; Reuter, V.E.; Reynolds, S.M.; Rhie, S.K.; Rieger-Christ, K.; Roach, J.; Robertson, A.G.; Robinson, B.; Rubin, M.A.; Saad, F.; Sadeghi, S.; Saksena, G.; Saller, C.; Salner, A.; Sanchez-Vega, F.; Sander, C.; Sandusky, G.; Sauter, G.; Sboner, A.; Scardino, P.T.; Scarlata, E.; Schein, J.E.; Schlomm, T.; Schmidt, L.S.; Schultz, N.; Schumacher, S.E.; Seidman, J.; Neder, L.; Seth, S.; Sharp, A.; Shelton, C.; Shelton, T.; Shen, H.; Shen, R.; Sherman, M.; Sheth, M.; Shi, Y.; Shih, J.; Shmulevich, I.; Simko, J.; Simon, R.; Simons, J.V.; Sipahimalani, P.; Skelly, T.; Sofia, H.J.; Soloway, M.G.; Song, X.; Sorcini, A.; Sougnez, C.; Stepa, S.; Stewart, C.; Stewart, J.; Stuart, J.M.; Sullivan, T.B.; Sun, C.; Sun, H.; Tam, A.; Tan, D.; Tang, J.; Tarnuzzer, R.; Tarvin, K.; Taylor, B.S.; Teebagy, P.; Tenggara, I.; Têtu, B.; Tewari, A.; Thiessen, N.; Thompson, T.; Thorne, L.B.; Tirapelli, D.P.; Tomlins, S.A.; Trevisan, F.A.; Troncoso, P.; True, L.D.; Tsourlakis, M.C.; Tyekucheva, S.; Van Allen, E.; Van Den Berg, D.J.; Veluvolu, U.; Verhaak, R.; Vocke, C.D.; Voet, D.; Wan, Y.; Wang, Q.; Wang, W.; Wang, Z.; Weinhold, N.; Weinstein, J.N.; Weisenberger, D.J.; Wilkerson, M.D.; Wise, L.; Witte, J.; Wu, C.C.; Wu, J.; Wu, Y.; Xu, A.W.; Yadav, S.S.; Yang, L.; Yang, L.; Yau, C.; Ye, H.; Yena, P.; Zeng, T.; Zenklusen, J.C.; Zhang, H.; Zhang, J.; Zhang, J.; Zhang, W.; Zhong, Y.; Zhu, K.; Zmuda, E. Cancer genome atlas research network. the molecular taxonomy of primary prostate cancer. Cell, 2015, 163(4), 1011-1025.
[http://dx.doi.org/10.1016/j.cell.2015.10.025] [PMID: 26544944]

Jerónimo, C.; Bastian, P.J.; Bjartell, A.; Carbone, G.M.; Catto, J.W.F.; Clark, S.J.; Henrique, R.; Nelson, W.G.; Shariat, S.F. Epigenetics in prostate cancer: biologic and clinical relevance. Eur. Urol., 2011, 60(4), 753-766.
[http://dx.doi.org/10.1016/j.eururo.2011.06.035] [PMID: 21719191]

Berger, M.F.; Lawrence, M.S.; Demichelis, F.; Drier, Y.; Cibulskis, K.; Sivachenko, A.Y.; Sboner, A.; Esgueva, R.; Pflueger, D.; Sougnez, C.; Onofrio, R.; Carter, S.L.; Park, K.; Habegger, L.; Ambrogio, L.; Fennell, T.; Parkin, M.; Saksena, G.; Voet, D.; Ramos, A.H.; Pugh, T.J.; Wilkinson, J.; Fisher, S.; Winckler, W.; Mahan, S.; Ardlie, K.; Baldwin, J.; Simons, J.W.; Kitabayashi, N.; MacDonald, T.Y.; Kantoff, P.W.; Chin, L.; Gabriel, S.B.; Gerstein, M.B.; Golub, T.R.; Meyerson, M.; Tewari, A.; Lander, E.S.; Getz, G.; Rubin, M.A.; Garraway, L.A. The genomic complexity of primary human prostate cancer. Nature, 2011, 470(7333), 214-220.
[http://dx.doi.org/10.1038/nature09744] [PMID: 21307934]

Barbieri, C.E.; Baca, S.C.; Lawrence, M.S.; Demichelis, F.; Blattner, M.; Theurillat, J.P.; White, T.A.; Stojanov, P.; Van Allen, E.; Stransky, N.; Nickerson, E.; Chae, S.S.; Boysen, G.; Auclair, D.; Onofrio, R.C.; Park, K.; Kitabayashi, N.; MacDonald, T.Y.; Sheikh, K.; Vuong, T.; Guiducci, C.; Cibulskis, K.; Sivachenko, A.; Carter, S.L.; Saksena, G.; Voet, D.; Hussain, W.M.; Ramos, A.H.; Winckler, W.; Redman, M.C.; Ardlie, K.; Tewari, A.K.; Mosquera, J.M.; Rupp, N.; Wild, P.J.; Moch, H.; Morrissey, C.; Nelson, P.S.; Kantoff, P.W.; Gabriel, S.B.; Golub, T.R.; Meyerson, M.; Lander, E.S.; Getz, G.; Rubin, M.A.; Garraway, L.A. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet., 2012, 44(6), 685-689.
[http://dx.doi.org/10.1038/ng.2279] [PMID: 22610119]

Frank, S.; Nelson, P.; Vasioukhin, V. Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects. F1000 Res.,, 2018 , 7(F1000 Faculty Rev ), 1173..
[http://dx.doi.org/10.12688/f1000research.14499.1] [PMID: 30135717]

Grasso, C.S.; Wu, Y.M.; Robinson, D.R.; Cao, X.; Dhanasekaran, S.M.; Khan, A.P.; Quist, M.J.; Jing, X.; Lonigro, R.J.; Brenner, J.C.; Asangani, I.A.; Ateeq, B.; Chun, S.Y.; Siddiqui, J.; Sam, L.; Anstett, M.; Mehra, R.; Prensner, J.R.; Palanisamy, N.; Ryslik, G.A.; Vandin, F.; Raphael, B.J.; Kunju, L.P.; Rhodes, D.R.; Pienta, K.J.; Chinnaiyan, A.M.; Tomlins, S.A. The mutational landscape of lethal castration-resistant prostate cancer. Nature, 2012, 487(7406), 239-243.
[http://dx.doi.org/10.1038/nature11125] [PMID: 22722839]

Shtivelman, E.; Beer, T.M.; Evans, C.P. Molecular pathways and targets in prostate cancer. Oncotarget, 2014, 5(17), 7217-7259.
[http://dx.doi.org/10.18632/oncotarget.2406] [PMID: 25277175]

Tomlins, S.A.; Rhodes, D.R.; Perner, S.; Dhanasekaran, S.M.; Mehra, R.; Sun, X.W.; Varambally, S.; Cao, X.; Tchinda, J.; Kuefer, R.; Lee, C.; Montie, J.E.; Shah, R.B.; Pienta, K.J.; Rubin, M.A.; Chinnaiyan, A.M. Recurrent fusion of tmprss2 and ets transcription factor genes in prostate cancer. Science, 2005, 310(5748), 644-648.
[http://dx.doi.org/10.1126/science.1117679]

Fraser, M.; Sabelnykova, V.Y.; Yamaguchi, T.N.; Heisler, L.E.; Livingstone, J.; Huang, V.; Shiah, Y.J.; Yousif, F.; Lin, X.; Masella, A.P.; Fox, N.S.; Xie, M.; Prokopec, S.D.; Berlin, A.; Lalonde, E.; Ahmed, M.; Trudel, D.; Luo, X.; Beck, T.A.; Meng, A.; Zhang, J.; D’Costa, A.; Denroche, R.E.; Kong, H.; Espiritu, S.M.G.; Chua, M.L.K.; Wong, A.; Chong, T.; Sam, M.; Johns, J.; Timms, L.; Buchner, N.B.; Orain, M.; Picard, V.; Hovington, H.; Murison, A.; Kron, K.; Harding, N.J.; P’ng, C.; Houlahan, K.E.; Chu, K.C.; Lo, B.; Nguyen, F.; Li, C.H.; Sun, R.X.; de Borja, R.; Cooper, C.I.; Hopkins, J.F.; Govind, S.K.; Fung, C.; Waggott, D.; Green, J.; Haider, S.; Chan-Seng-Yue, M.A.; Jung, E.; Wang, Z.; Bergeron, A.; Dal Pra, A.; Lacombe, L.; Collins, C.C.; Sahinalp, C.; Lupien, M.; Fleshner, N.E.; He, H.H.; Fradet, Y.; Tetu, B.; van der Kwast, T.; McPherson, J.D.; Bristow, R.G.; Boutros, P.C. Genomic hallmarks of localized, non-indolent prostate cancer. Nature, 2017, 541(7637), 359-364.
[http://dx.doi.org/10.1038/nature20788] [PMID: 28068672]

van Dessel, L.F.; van Riet, J.; Smits, M.; Zhu, Y.; Hamberg, P.; van der Heijden, M.S.; Bergman, A.M.; van Oort, I.M.; de Wit, R.; Voest, E.E.; Steeghs, N.; Yamaguchi, T.N.; Livingstone, J.; Boutros, P.C.; Martens, J.W.M.; Sleijfer, S.; Cuppen, E.; Zwart, W.; van de Werken, H.J.G.; Mehra, N.; Lolkema, M.P. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact. Nat. Commun., 2019, 10(1), 5251.
[http://dx.doi.org/10.1038/s41467-019-13084-7] [PMID: 31748536]

Gan, Y.; Li, Y.; Long, Z.; Lee, A.R.; Xie, N.; Lovnicki, J.M.; Tang, Y.; Chen, X.; Huang, J.; Dong, X. Roles of alternative rna splicing of the bif-1 gene by srrm4 during the development of treatment-induced neuroendocrine prostate cancer. EBioMedicine, 2018, 31, 267-275.
[http://dx.doi.org/10.1016/j.ebiom.2018.05.002] [PMID: 29759485]

Flores-Morales, A.; Bergmann, T.B.; Lavallee, C.; Batth, T.S.; Lin, D.; Lerdrup, M.; Friis, S.; Bartels, A.; Kristensen, G.; Krzyzanowska, A.; Xue, H.; Fazli, L.; Hansen, K.H.; Røder, M.A.; Brasso, K.; Moreira, J.M.; Bjartell, A.; Wang, Y.; Olsen, J.V.; Collins, C.C.; Iglesias-Gato, D. Proteogenomic characterization of patient-derived xenografts highlights the role of rest in neuroendocrine differentiation of castration-resistant prostate cancer. Clin. Cancer Res., 2019, 25(2), 595-608.
[http://dx.doi.org/10.1158/1078-0432.CCR-18-0729] [PMID: 30274982]

Armenia, J.; Wankowicz, S.A.M.; Liu, D.; Gao, J.; Kundra, R.; Reznik, E.; Chatila, W.K.; Chakravarty, D.; Han, G.C.; Coleman, I.; Montgomery, B.; Pritchard, C.; Morrissey, C.; Barbieri, C.E.; Beltran, H.; Sboner, A.; Zafeiriou, Z.; Miranda, S.; Bielski, C.M.; Penson, A.V.; Tolonen, C.; Huang, F.W.; Robinson, D.; Wu, Y.M.; Lonigro, R.; Garraway, L.A.; Demichelis, F.; Kantoff, P.W.; Taplin, M.E.; Abida, W.; Taylor, B.S.; Scher, H.I.; Nelson, P.S.; de Bono, J.S.; Rubin, M.A.; Sawyers, C.L.; Chinnaiyan, A.M.; Schultz, N.; Van Allen, E.M. PCF/SU2C International prostate cancer dream team. the long tail of oncogenic drivers in prostate cancer. Nat. Genet., 2018, 50(5), 645-651.
[http://dx.doi.org/10.1038/s41588-018-0078-z] [PMID: 29610475]

Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell, 2000, 100(1), 57-70.
[http://dx.doi.org/10.1016/S0092-8674(00)81683-9] [PMID: 10647931]

Latonen, L.; Afyounian, E.; Jylhä, A.; Nättinen, J.; Aapola, U.; Annala, M.; Kivinummi, K.K.; Tammela, T.T.L.; Beuerman, R.W.; Uusitalo, H.; Nykter, M.; Visakorpi, T. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. Nat. Commun., 2018, 9(1), 1176.
[http://dx.doi.org/10.1038/s41467-018-03573-6] [PMID: 29563510]

Charmpi, K.; Guo, T.; Zhong, Q.; Wagner, U.; Sun, R.; Toussaint, N.C.; Fritz, C.E.; Yuan, C.; Chen, H.; Rupp, N.J.; Christiansen, A.; Rutishauser, D.; Rüschoff, J.H.; Fankhauser, C.; Saba, K.; Poyet, C.; Hermanns, T.; Oehl, K.; Moore, A.L.; Beisel, C.; Calzone, L.; Martignetti, L.; Zhang, Q.; Zhu, Y.; Martínez, M.R.; Manica, M.; Haffner, M.C.; Aebersold, R.; Wild, P.J.; Beyer, A. Proteogenomic heterogeneity of localized human prostate cancer progression. bioRxiv, 2020. (In press).

Drake, J.M.; Paull, E.O.; Graham, N.A.; Lee, J.K.; Smith, B.A.; Titz, B.; Stoyanova, T.; Faltermeier, C.M.; Uzunangelov, V.; Carlin, D.E.; Fleming, D.T.; Wong, C.K.; Newton, Y.; Sudha, S.; Vashisht, A.A.; Huang, J.; Wohlschlegel, J.A.; Graeber, T.G.; Witte, O.N.; Stuart, J.M. Phosphoproteome integration reveals patient-specific networks in prostate cancer. Cell, 2016, 166(4), 1041-1054.
[http://dx.doi.org/10.1016/j.cell.2016.07.007] [PMID: 27499020]

Drake, J.M.; Graham, N.A.; Lee, J.K.; Stoyanova, T.; Faltermeier, C.M.; Sud, S.; Titz, B.; Huang, J.; Pienta, K.J.; Graeber, T.G.; Witte, O.N. Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proc. Natl. Acad. Sci. USA, 2013, 110(49), E4762-E4769.
[http://dx.doi.org/10.1073/pnas.1319948110]

Sinha, A.; Huang, V.; Livingstone, J.; Wang, J.; Fox, N.S.; Kurganovs, N.; Ignatchenko, V.; Fritsch, K.; Donmez, N.; Heisler, L.E.; Shiah, Y.J.; Yao, C.Q.; Alfaro, J.A.; Volik, S.; Lapuk, A.; Fraser, M.; Kron, K.; Murison, A.; Lupien, M.; Sahinalp, C.; Collins, C.C.; Tetu, B.; Masoomian, M.; Berman, D.M.; van der Kwast, T.; Bristow, R.G.; Kislinger, T.; Boutros, P.C. The proteogenomic landscape of curable prostate cancer. Cancer Cell, 2019, 35(3), 414-427.
[http://dx.doi.org/10.1016/j.ccell.2019.02.005] [PMID: 30889379]

Kwon, O.K.; Jeon, J.M.I.; Sung, E.; Na, A.Y.; Kim, S.J.; Lee, S. Comparative secretome profiling and mutant protein identification in metastatic prostate cancer cells by quantitative mass spectrometry-based proteomics. Cancer Genomics Proteomics, 2018, 15(4), 279-290.
[http://dx.doi.org/10.21873/cgp.20086] [PMID: 29976633]

Latonen, L.; Nykter, M.; Visakorpi, T. Proteomics of prostate cancer - revealing how cancer cells master their messy genomes. Oncoscience, 2018, 5(7-8), 216-217.
[http://dx.doi.org/10.18632/oncoscience.453] [PMID: 30234142]

Anamika, K.; Verma, S.; Jere, A.; Desai, A. Transcriptomic profiling using next generation sequencing - advances, advantages, and challenges;, InTechOpen: London, . 2016. .
[http://dx.doi.org/10.5772/61789]

Carleton, N.M.; Lee, G.; Madabhushi, A.; Veltri, R.W. Advances in the computational and molecular understanding of the prostate cancer cell nucleus. J. Cell. Biochem., 2018, 119(9), 7127-7142.
[http://dx.doi.org/10.1002/jcb.27156] [PMID: 29923622]

Jackson, D.H.; Banks, R.E. Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation. Proteomics Clin. Appl., 2010, 4(3), 250-270.
[http://dx.doi.org/10.1002/prca.200900220] [PMID: 21137047]

Scher, H.I.; Morris, M.J.; Larson, S.; Heller, G. Validation and clinical utility of prostate cancer biomarkers. Nat. Rev. Clin. Oncol., 2013, 10(4), 225-234.
[http://dx.doi.org/10.1038/nrclinonc.2013.30] [PMID: 23459624]

Li, Y.; Vongsangnak, W.; Chen, L.; Shen, B. Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression. BMC Med. Genomics, 2014, 7(Suppl. 1), S3.
[http://dx.doi.org/10.1186/1755-8794-7-S1-S3] [PMID: 25080090]

Ramnarine, V.R.; Kobelev, M.; Gibb, E.A.; Nouri, M.; Lin, D.; Wang, Y.; Buttyan, R.; Davicioni, E.; Zoubeidi, A.; Collins, C.C. The evolution of long noncoding rna acceptance in prostate cancer initiation, progression, and its clinical utility in disease management. Eur. Urol., 2019, 76(5), 546-559.

Boerrigter, E.; Groen, L.N.; Van Erp, N.P.; Verhaegh, G.W.; Schalken, J.A. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies. Expert Rev. Mol. Diagn., 2020, 20(2), 219-230.
[http://dx.doi.org/10.1080/14737159.2019.1675515] [PMID: 31577907]